Results of The Population PK Modelling of RTXMB83, A Rituximab Biosimilar Candidate in Patients with Diffuse Large B-Cell Lymphoma (DLBCL)

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions